ABSTRACT. Chediak-Higashi Syndrome (CHS) has been associated with recurrent bacterial infections and defective polymorphonuclear (PMN) leukocyte function. Confirmation of the diagnosis of CHS and defective PMN function was established in a 2-month-old with accelerated phase CHS. The diagnosis was confirmed by demonstrating reduced PMN degranulation (@-glucuronidase release 34.1 f 0.9% versus 5
' Presented in part at the Society of Pediatric Research, Washington, DC, May 1988. CHS, a rare, autosomal recessive disorder in children, is characterized by recurrent severe pyogenic infections, partial oculocutaneous albinism, photophobia, and the presence of abnormally large granules in PMN and other granule-containing cells (1) . Most children with this syndrome eventually develop an accelerated phase manifested by fever, hepatosplenomegaly, lymphadenopathy, pancytopenia, bleeding tendencies, neurologic changes, and diffuse mononuclear cell infiltrates (2) . The hallmark and pathognomonic abnormality of this disorder is the presence of giant lysosomal granules within the cytoplasm of granule-containing hematopoietic and nonhematopoietic cells.
Rausch et al. (3) , using immunocytochemical methods, have demonstrated abnormal PMN lysosomal enzyme contents (myeloperoxidase, lysozyme, elastase, lactofenin) in primary and secondary granules in CHS. The content of other lysosomal granular proteins, such as the C3bi receptor, a glycoprotein important in PMN phagocytosis and adherence, has not been previously examined in CHS. Additionally, there is a large variation in the size of inclusions or granules in patients with CHS. Recently, flow cytometry has been reported to reflect the degree of granularity in human neutrophils and assess the state of neutrophil activation (4) . It remains to be determined whether the variation in granular density observed in the CHS PMN is secondary to a net increase or decrease or just abnormal fusion of previous existing granular components. We investigated the expression of another granular lysosomal protein, C3bi (MOl), and additionally, the approximate total cell density of PMN in a 2-month-old, newly diagnosed with CHS. We used FACS analysis with OKMl monoclonal antibody for MOI receptor expression and side scatter analysis (right angle scatter) for total cell density and granule content.
CASE REPORT D.M., a 9-wk-old male, presented with a history of fever, irritability, and lethargy. His past family and medical history was unremarkable; he had a normal Cyr-old sibling. He presented in obvious septic shock, with multiple petechiae, partial oculocutaneous albinism, moderate hepatosplenomegaly, and lymphadenopathy. His complete blood count revealed a white blood cell count of 5.3/mm3, 6% PMN, 2% bands, 80% lymphocytes and 5% monocytes with abnormally large PMN granular inclusions, platelet count 64,000/mm3, Hb 5.9 g/dl, PT 18, PTT 70, and a peripheral smear consistent with disseminated intravascular coagulation. Bone marrow aspirate confirmed the large granular inclusions and subsequent PMN functional analysis confirmed the diagnosis of CHS in the accelerated phase. Treatment included fluids, vasoactive drugs, blood products, and antibiotics; stabilization occurred within 48 h. He was placed on prednisone but continued to have severe thrombocytopenia (platelet count 5 20,000/mm3). Failing to respond to steroids, he was given a course of IVIG-Sandoglobulin 400 mg/kg/day for 5 days (Sandoz, Inc., East Hanover, NJ). This treatment stabilized his platelet count above 100,000/mm3. He was readmitted 2 wk later with another episode of sepsis and persistent thrombocytopenia. He was then given a course of ATG (ATGAM, Upjohn, Kalamazoo, MI), at 15 mg/kg/day x 10 days. ATG treatment slowed his accelerated process for 4 wk until he was readmitted again for sepsis and severe consumption coagulopathy. He eventually succumbed to this septic process despite vigorous medical support, including PMN transfusions.
MATERIALS AND METHODS
Heparinized venous blood was drawn from normal volunteers in accordance with the principles of the Declaration of Helsinki, as previously described (5) . The red blood cells were allowed to sediment, after the addition of 6% dextran-70 in 0.9% saline (McGaw Laboratories, Irvine, CA). The leukocyte-enriched plasma was collected, layered on a ficoll-hypaque gradient ( p = 1.099), and centrifuged for 30 rnin (5) . PMN cells were recovered in the cell pellet, and any remaining erythrocytes were hemolyzed by hypotonic lysis. Isolated PMN were then suspended in phosphate-buffered saline, pH 7.4, with 5 mM glucose at various concentrations depending on particular assay requirements.
Degranulation. PMN production of lysozyme and @-glucuronidase activity was measured in patient and control cells after the addition of cytochalasin B (2.1 mM) and stimulation with FMLP M) at 37" C for 5 min. P-glucuronidase levels were determined by adding p-nitrophenyl-b-d-glucuronide (2.0 mM), sodium acetate buffer (100 mM, pH 4.6), and triton-X-100 (1%) to aliquots of the cell samples. The reaction mixture was incubated overnight at 37" C, and stopped by the addition of NaOH (0.1 N). Supernatants were measured against a reagent blank at an optical density of 410 nm, and the results were reported as percentage enzyme release/107 cells (6) . Lysozyme production was measured using Micrococcus lysodeikticus (Worthington Biochemical Corp., Freehold, NJ) as the substrate (Sigma, St. Louis, MO.). Cell samples were added to this substrate, and the decrease in absorbance at optical density 515 recorded on the spectrophotometer (Gilford, Oberlin, OH). Enzyme activity was reported as percentage enzyme release/107 cells (7) . Aliquots of each sample for all assays were lysed with 1.0% triton X-100 to obtain 100% resting reference values.
Bacterial killing. Bacterial killing was measured by a modification of the Quie method (8). After we subcultured Staphylococcus aureus to obtain maximum phase growth, the bacteria was opsonized with human AB serum for 10 min. Aliquots of control and patient PMN were added to the bacteria and incubated for 15 min at 37" C. Aliquots of the suspension were then serially diluted in sterile water and plated in warm nutrient agar. Colony growth was tabulated after overnight incubation, and results are expressed as percentage bacteria killed at 15 min.
Receptor assays. Control and patient PMN were suspended in sterile phosphate-buffered saline, and cytochalasin B (2. 
RESULTS
During the period this patient was not being treated with corticosteroids, PMN enzyme degranulation was compared to a normal aged-matched control FMLP induced PMN release of @-glucuronidase and lysozyme was significantly decreased compared to controls (Fig. 1) . Staphyloccocal bacterial killing at 15 rnin was reduced by more than 50% compared to controls (5 1.4 versus 24.9%). FMLP stimulated PMN in this CHS patient expressed only 13% of C3bi receptors compared to controls as measured by OKMl FACS analysis (Fig. 2) . Resting mean fluorescence of both patient and control were the same. Finally, right angle light scatter analysis of PMN total cell density in this patient with CHS was not statistically different from that of agematched controls (D s 0.01) (Fig. 3) . PMNs in quadrant 1 were used to measure right angle scatter. Additionally, a second population of lymphocytes were seen in quadrant 2. The difference between control and CHS in this second population probably reflects the different degree of neutropenia in the patient with CHS in the accelerated phase. This cell population was used only in the population of PMNs from quadrant 1, not in the analysis of right angle scatter. DISCUSSION PMN from normal individuals usually contain at least three distinctive populations of granules, azurophilic or primary, specific or secondary and tertiary granules. Azurophilic granules usually first develop in promyelocytes and contain enzymes such as myeloperoxidase, elastase, cathespin G, lysozyme, acid phosphatase and other acid hydrolases (10) . Specific granules develop in myelocytes, during a later stage in development, and contain lysozyme, lactoferrin, vitamin B1l binding protein and other glycoproteins (1 1). Tertiary granules contain enzymes such as gelatinase and possibly C3bi receptors or MO 1 glycoprotein.
Significant reductions in CHS PMN enzyme activity was initially documented for myeloperoxidase and @-glucuronidase (34 and 48% of normal, respectively) (1 I). Using a more recent immunofluorescent technique, subsequent studies suggested that the abnormally large inclusions characteristic of CHS granules were the result of progressive aggregation and fusion of normal azurophilic and specific granules. These deficient granules were later found to contain deficiencies of other enzymes of primary (azurophilic) and secondary (specific) granules such as elastase, cathespin G, and lactofemn (3) . Specific determination of the granular activities of other glycoproteins such as M01 have not been previously examined in CHS.
The M 0 1 glycoprotein found on the surfaces of granulocytes and monocytes is a heterodimer with an a-subunit of 155 kDa and a shared common @-subunit of 94 kDa found on other hematopoietic cells (12) . M01, identical to other glycoproteins known in the literature as OKMl and MAC-1, serves as the receptor for C3bi opsonized particles (13) . A number of degran-ulating stimuli "up-regulate" the expression of MO 1 and enhance C3bi receptor activity on granulocytes and monocytes (14) . This increase in expression of M01 appears to be secondary to the translocation of a large intragranular pool of this glycoprotein to the cell surface membrane pool (15) .
The subcellular localization of this glycoprotein was initially postulated to be enriched in the specific granular fraction and possibly the membrane fraction of the PMN (15) . Recent data, however, suggest that another pool of M01 glycoprotein may exist in tertiary granules or gelatinase containing organelles of PMN (16) . The recent report of a new novel intracellular com-
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partment, containing 70% of PMN alkaline phosphatase, has now been identified to be distinct from primary, secondary, and tertiary granules and to be plasma membrane (17) . This compartment has been found to translocate fully to the plasma membrane after stimulation with FMLP. Because C3bi receptors translocate within the PMN (in a similar fashion to alkaline phosphatase), this newly discovered compartment may also contain measurable amounts of C3bi. Regardless of the location of the subcellular granular pool of MO1, this glycoprotein plays an important role in PMN adhesion, chemotaxis, aggregation, opsonization, and phagocytosis. This study documenting downregulation or decreased release of this granule-containing glycoprotein may contribute to our understanding of the susceptibility of patients with CHS to recurrent bacterial infections secondary ' , to defective PMN mobility, chemotaxis, and bactericidal activity (1).
White et al. (18) recently demonstrated a wide variation in the size of myeloperoxidase positive organelles in CHS, ranging from small vesicles or normal-sized lysosomes, to the large inclusions characteristic of this disorder. With this wide variation in granule size in CHS, we attempted to determine whether the total cell density of PMN in this syndrome was different from normal agematched controls. Fletcher et al. (4) demonstrated that loss of right angle side scatter as measured by flow cytometry related closely to the secretion of primary granules, whereas changes in forward scatter reflects alteration in cel&shape and/or surface volume ratios that accompany cell activation. Because right angle scatter or Side Scatter Analysis measures totaLcell density, we used immunofluorescent analvsis with the FACPto answer this question. Additionally, we iivestigated whether this method could be used as a diagnostic tool in this syndrome. Our results revealed, however, that the total cell density, at least as measured by FACS analysis, is no different between,CHS and controls, suggesting that total cell granularity is similar. We did not directly measure the granule pool simultaneously with our right angle scatter analysis. Because right angle scatter measures total cell density, including states of actin polymerization, further studies are needed to correlate cell density and granular pool content in CHS.
In summary, this study demonstrated that stimulated CHS PMN expressed reduced amounts of other lysosomal glycoproteins, including MOI, from those enzymes that have previously been reported. The abnormally pathognomonic large protein containing granule expressed in CHS PMNs may be the result of fusion of primary, secondary, and now, possibly, tertiary granules. Alternatively, decreased M 0 1 glycoprotein expression may be secondary to defective lysosomal and cellular membrane function as recently suggested by Haak et al. (19) . Regardless of the mechanism, further studies are needed to correlate this finding of decreased MO 1 expression to defective PMN function, including PMN adhesion in CHS and its relationship to recurrent infections.
